GlaxoSmithKline PLC — Director's Dealing 2016

Nov 4, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4302O

GlaxoSmithKline PLC

04 November 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr M M Slaoui

b)

Position/status

Chairman, Global Vaccines

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

GlaxoSmithKline plc American Depositary Shares ('ADSs')

ISIN: US37733W1053

b)

Nature of the transaction

An increase of 22 ADS following the notional allocation of ADSs on 3 November 2016, at a price of $38.74 per ADS, as a result of the revaluation of the cash element of the notional investment held within the GSK 401(K) plan.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
$38.74	22

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2016-11-03

f)

Place of the transaction

n/a

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr K Slaoui

b)

Position/status

PCA of Dr M M Slaoui (Chairman, Global Vaccines)

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

GlaxoSmithKline plc American Depositary Shares ('ADSs')

ISIN: US37733W1053 

b)

Nature of the transaction

An increase of 3 ADS following the notional allocation of ADSs on 3 November 2016, at a price of $38.74 per ADS, as a result of the revaluation of the cash element of the notional investment held within the GSK 401(K) plan.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
$38.74	3

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2016-11-03

f)

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDZLFBQFFFFBF

//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'OXTQOs4zQHhStVD_rWMSy1VYp3MxSy3cW4sXoacHPgQAOd9ogQxlMFiFAsNm4iAIhD5Ill9c57Gpk--hk1KgV1zoGjXsF6uZ2ga94qn20O41:PWLkQs9AdWoFw69YU2zFAYgEwiPGOrLt7z0rOaaLm-t6pVXAgrt2XWenv-thfsJbJvJDN91iKVMdfLeYlcmEg3v013d4VAlq9yblHa-6xtY1'}});//]]>